Cosentyx is a biologic that was approved for the treatment of psoriasis in 2015 and for the treatment of psoriatic arthritis in 2016.

What is Cosentyx?

Cosentyx (also known by its generic name secukinumab) was approved by the FDA for the treatment of moderate-to-severe plaque psoriasis in adults in January 2015 and approved for use in children 6 years and older in June 2021. Cosentyx is also approved to treat people with active psoriatic arthritis (PsA) ages 2 years and older.

For people with plaque psoriasis, Cosentyx is administered by injection under the skin at weeks 0, 1, 2, 3, and 4 and then every 4 weeks. Health care providers may recommend a different dosing schedule for patients with PsA. Cosentyx is also available as an intravenous (IV) infusion for adults with PsA.

To learn more, please visit the Cosentyx website.

An Asian woman with short hair cooks dinner while camping.

New Cosentyx® Formulation for PsA

Cosentyx® is now available for IV infusion at a health care provider's office.

Read more
Loudspeaker animated image

Cosentyx Receives FDA Approval for Psoriatic Arthritis

Hard-to-treat psoriasis and psoriatic arthritis improves significantly on the biologic drug.

Discover more

FDA Approves Cosentyx for Pediatric Patients

The FDA has approved the use of Cosentyx in patients 6 years old and older who are candidates for systemic therapy or phototherapy.

Read article

Learn More About Your Treatment Options

The Patient Navigation Center is here to provide personalized information about your psoriasis and psoriatic arthritis treatment.

Contact a Patient Navigator today

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.